Published in Med Phys on June 12, 1992
Premenopausal overweight women do not lose bone during moderate weight loss with adequate or higher calcium intake. Am J Clin Nutr (2007) 1.03
Random field assessment of inhomogeneous bone mineral density from DXA scans can enhance the differentiation between postmenopausal women with and without hip fractures. J Biomech (2015) 0.95
Comparison of different techniques to measure body composition in moderately active adolescents. Br J Sports Med (1998) 0.88
Comparative evaluation among different materials to replace soft tissue in oral radiology studies. J Appl Oral Sci (2010) 0.88
Determination of linear x-ray attenuation coefficients of pathological brain tissues and use of filters in tissue contrast enhancement in computed tomography. Eurasian J Med (2010) 0.75
Comparison of intraoral radiography and cone-beam computed tomography for the detection of periodontal defects: an in vitro study. BMC Oral Health (2015) 0.75
Attenuating trabecular morphology associated with low magnesium diet evaluated using micro computed tomography. PLoS One (2017) 0.75
Stochastic predictors from the DXA scans of human lumbar vertebrae are correlated with the microarchitecture parameters of trabecular bone. J Biomech (2015) 0.75
Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med (2001) 9.57
Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study. J Clin Oncol (2002) 2.61
A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med (1998) 2.42
Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene. Nat Genet (1996) 2.23
Effects of IL-12 on helper T cell-dependent immune responses in vivo. J Immunol (1994) 2.11
Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med (1996) 1.99
Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol (1998) 1.94
Skeletal effects of oral oestrogen compared with subcutaneous oestrogen and testosterone in postmenopausal women. BMJ (1988) 1.89
Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosis. Br J Obstet Gynaecol (1992) 1.74
Bone densitometry: current status and future prospects. Br J Radiol (1997) 1.57
Periprosthetic bone remodelling of two types of uncemented femoral implant with proximal hydroxyapatite coating: a 3-year follow-up study addressing the influence of prosthesis design and preoperative bone density on periprosthetic bone loss. Osteoporos Int (2003) 1.56
The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population. Occup Med (Lond) (1998) 1.56
Late low-dose steroid withdrawal in renal transplant recipients increases bone formation and bone mineral density. Am J Transplant (2006) 1.51
Contact quantitative ultrasound: an evaluation of precision, fracture discrimination, age-related bone loss and applicability of the WHO criteria. Osteoporos Int (1999) 1.51
Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate. Semin Nucl Med (2001) 1.49
1alpha-hydroxyvitamin D3 in primary hyperparathyroidism. Clin Endocrinol (Oxf) (1977) 1.48
Circulating fibroblast growth factor-23 increases following intermittent parathyroid hormone (1-34) in postmenopausal osteoporosis: association with biomarker of bone formation. Calcif Tissue Int (2010) 1.48
Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease. Lancet (1984) 1.45
Bone scan flare predicts successful systemic therapy for bone metastases. J Nucl Med (1988) 1.44
Occupational dose to the radiographer in dual X-ray absorptiometry: a comparison of pencil-beam and fan-beam systems. Br J Radiol (1996) 1.41
Ablation of mediastinal parathyroid adenomas by superselective embolization of the internal mammary artery with alcohol. Clin Radiol (1993) 1.39
1, 2, 3, or 4 phase bone imaging--how many are necessary? Nucl Med Commun (1990) 1.39
Training of staff for the delivery of PET/CT services in the UK. Nucl Med Commun (2006) 1.39
The role of nuclear medicine in orthopaedics. Nucl Med Commun (1994) 1.39
Absorption of oral diphosphonate in normal subjects. Clin Endocrinol (Oxf) (1986) 1.38
Hypercalcaemia of malignancy: evidence for a nonparathyroid humoral agent with an effect on renal tubular handling of calcium. Clin Sci (Lond) (1984) 1.36
Visual assessment of vertebral deformity by X-ray absorptiometry: a highly predictive method to exclude vertebral deformity. Osteoporos Int (2000) 1.30
The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease. J Nucl Med (1978) 1.30
Can the WHO criteria for diagnosing osteoporosis be applied to calcaneal quantitative ultrasound? Osteoporos Int (2000) 1.25
Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine. Eur J Nucl Med (1999) 1.24
A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases. Eur J Cancer (1997) 1.20
Survival analyses from the ZEBRA study. goserelin (Zoladex) versus CMF in premenopausal women with node-positive breast cancer. Eur J Cancer (2003) 1.20
Chronic low back pain: comparison of bone SPECT with radiography and CT. Radiology (1992) 1.18
Hydralazine, antinuclear antibodies, and the lupus syndrome. Br Med J (Clin Res Ed) (1982) 1.17
A placebo- and imipramine-controlled study of paroxetine. Psychopharmacol Bull (1990) 1.16
Hypercalcaemia and metastatic bone disease: is there a causal link? Lancet (1982) 1.15
A clinical profile of back pain and disability in patients with spinal osteoporosis. Bone (1994) 1.14
Identification and cloning of a connective tissue growth factor-like cDNA from human osteoblasts encoding a novel regulator of osteoblast functions. J Biol Chem (1999) 1.14
Circumcision and periurethral carriage of Proteus mirabilis in boys. Arch Dis Child (1988) 1.14
Analysis of IL-2, IL-4, and IFN-gamma-producing cells in situ during immune responses to protein antigens. J Immunol (1993) 1.13
Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness. Calcif Tissue Int (2012) 1.13
Reversal of Hartmann's procedure: effect of timing and technique on ease and safety. Dis Colon Rectum (1994) 1.12
Technical principles of dual energy x-ray absorptiometry. Semin Nucl Med (1997) 1.12
The role of nuclear medicine in monitoring treatment in skeletal malignancy. Semin Nucl Med (2001) 1.12
Bone mineral measurements in clinical practice. Br J Hosp Med (1987) 1.11
The relationship between plasma estradiol and the increase in bone density in postmenopausal women after treatment with subcutaneous hormone implants. Am J Obstet Gynecol (1990) 1.10
Fluorine-18-FDG PET in Paget's disease of bone. J Nucl Med (1997) 1.10
Management of male osteoporosis: report of the UK Consensus Group. QJM (1998) 1.10
The role of positron emission tomography in the management of bone metastases. Cancer (2000) 1.10
The value of SPECT scans in identifying back pain likely to benefit from facet joint injection. Br J Rheumatol (1996) 1.09
Quantitative ultrasound and bone mineral density are equally strongly associated with risk factors for osteoporosis. J Bone Miner Res (2001) 1.08
Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease. Osteoporos Int (2009) 1.08
Hypercalcaemic osteomalacia due to aluminium toxicity. Lancet (1982) 1.08
cDNA cloning of a novel, developmentally regulated immediate early gene activated by fibroblast growth factor and encoding a nuclear protein. J Biol Chem (1997) 1.08
Reappraisal of the baseline bone scan in breast cancer. J Nucl Med (1988) 1.07
Biochemical prediction of response of bone metastases to treatment. Br J Cancer (1988) 1.07
Oral surgery: ARONJ masterclass. Br Dent J (2014) 1.06
Morphometric X-ray absorptiometry and morphometric radiography of the spine: a comparison of prevalent vertebral deformity identification. J Bone Miner Res (2000) 1.06
Asymmetric orbital-lattice interactions in ultrathin correlated oxide films. Phys Rev Lett (2011) 1.06
Estimation of skeletal involvement in primary hyperparathyroidism. Use of 24-hour whole-body retention of technetium-99m diphosphonate. Ann Intern Med (1980) 1.05
Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy. Br Med J (Clin Res Ed) (1984) 1.05
The role of positron emission tomography in skeletal disease. Semin Nucl Med (2001) 1.04
Non-invasive assessment of skeletal kinetics using fluorine-18 fluoride positron emission tomography: evaluation of image and population-derived arterial input functions. Eur J Nucl Med (1999) 1.04
'Sink or swim': an evaluation of the clinical characteristics of individuals with high bone mass. Osteoporos Int (2011) 1.03
Too much heparin: possible source of error in blood gas analysis. Br Med J (Clin Res Ed) (1983) 1.02
Effect of increasing vertebral marrow fat content on BMD measurement, T-Score status and fracture risk prediction by DXA. Bone (2008) 1.02
Long-term precision of DXA scanning assessed over seven years in forty postmenopausal women. Osteoporos Int (2000) 1.02
Osteocalcin: a potential marker of metastatic bone disease and response to treatment. Eur J Cancer Clin Oncol (1988) 1.02
Enhanced ordering temperatures in antiferromagnetic manganite superlattices. Nat Mater (2009) 1.00
Vitamin D and bone mineral density. Osteoporos Int (1998) 0.99
Extra-articular features of benign joint hypermobility syndrome. Br J Rheumatol (1996) 0.99
Tranquillizers can block mitogenesis in 3T3 cells and induce differentiation in Friend cells. Nature (1980) 0.99
Fractal signature analysis of macroradiographs measures trabecular organization in lumbar vertebrae of postmenopausal women. Calcif Tissue Int (1994) 0.99
Bone scintigraphy in benign bone disease. Br Med J (Clin Res Ed) (1984) 0.99
Bone mineral density in professional female dancers. Br J Sports Med (1997) 0.98
The role of bone scanning in osteomalacia. J Nucl Med (1978) 0.97
Quantification of skeletal kinetic indices in Paget's disease using dynamic 18F-fluoride positron emission tomography. J Bone Miner Res (2002) 0.97
Comparison of clinical, radionuclide, and radiographic features of osteoarthritis of the hands. Ann Rheum Dis (1991) 0.97
Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women. Lancet (1995) 0.96
The prevention of early postmenopausal bone loss by cyclical etidronate therapy: a 2-year, double-blind, placebo-controlled study. Am J Med (1997) 0.95
A low dose regime of 1 alpha hydroxyvitamin D3 in the management of senile osteoporosis: a pilot study. Clin Endocrinol (Oxf) (1980) 0.95
Clinical value of adrenal androgen measurement in the diagnosis of delayed puberty. Lancet (1981) 0.95
Bone scintigraphy in metabolic bone disease. Semin Nucl Med (1997) 0.95
Envenomation by the scorpion Centruroides sculpturatus. J Toxicol Clin Toxicol (1984) 0.94
The effect of season and vitamin D supplementation on bone mineral density in healthy women: a double-masked crossover study. Osteoporos Int (2001) 0.94
The value of bone scintigraphy in the evaluation of osteoporotic patients with back pain. Scand J Rheumatol (2002) 0.94
Screening for osteopenia and osteoporosis: do the accepted normal ranges lead to overdiagnosis? Osteoporos Int (1997) 0.93
Digital hydrofluoric acid burns: treatment with intraarterial calcium infusion. Ann Emerg Med (1986) 0.92
Multisite quantitative ultrasound: precision, age- and menopause-related changes, fracture discrimination, and T-score equivalence with dual-energy X-ray absorptiometry. Osteoporos Int (2001) 0.92
Dual X-ray absorptiometry: a comparison between fan beam and pencil beam scans. Br J Radiol (1993) 0.92
Autoparathyroidectomy: a case report. Br J Surg (1979) 0.92
Fracture thresholds in osteoporosis: implications for hormone replacement treatment. Ann Rheum Dis (1992) 0.91
The bone scan: where are we now? Semin Nucl Med (1995) 0.91
Bone secondaries in breast cancer: the solitary metastasis. J Nucl Med (1989) 0.90
Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene. J Endocrinol (2003) 0.90
Effect of a 300 000-IU loading dose of ergocalciferol (Vitamin D2) on circulating 1,25(OH)2-vitamin D and fibroblast growth factor-23 (FGF-23) in vitamin D insufficiency. J Clin Endocrinol Metab (2013) 0.90